3117 |
TAVR Future Directions: New Technology and New Clinical Indications |
E Murat Tuzcu |
Apr. 20. 15 |
3116 |
Natural History of Aortic Dissection: Optimal Candidate for TEVAR |
Jong-Min Song |
Apr. 20. 15 |
3115 |
Autopsy Studies of TAVR - What Have We Learnt? |
Renu Virmani |
Apr. 20. 15 |
3114 |
[Special Lecture] Promoting Cardiovascular Health(2015-2020): A Fast Evolving Trend, Locally and Globally |
Valentin Fuster |
Apr. 20. 15 |
3113 |
More Than Twelve Months! |
Cheol Whan Lee |
Apr. 20. 15 |
3112 |
Theoretical Construct: Why BRS May Change the Landscape of Coronary Intervention? |
Patrick W. Serruys |
Apr. 20. 15 |
3111 |
Six Months Enough! |
David Joel Cohen |
Apr. 20. 15 |
3110 |
Bioresorbable Scaffolds in Complex Coronary Lesions |
Corrado Tamburino |
Apr. 20. 15 |
3109 |
Beyond IVUS: OCT, NIRS, and Beyond |
Akiko Maehara |
Apr. 20. 15 |
3108 |
Vulnerable Plaque Detection and Treatment: PROSPECT II and PROSPECT ABSORB |
Gregg W. Stone |
Apr. 20. 15 |